GlobeNewswire Inc.··Robbins LlpAtara Stock Crashes on FDA Rejection; Class Action Lawsuit Filed Over Alleged Disclosure Failures
Robbins LLP files class action against $ATRA over undisclosed manufacturing issues tied to FDA rejection of lead drug tabelecleucel, citing 57% stock plunge.
ATRAsecurities fraudclass action lawsuit